UK Companies House feature
MILLICENT PHARMA (NI) LIMITED
Profile
- Company number
- NI653555
- Status
- Active
- Incorporation
- 2018-06-07
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis. The Company meets its day-to-day working capital requirements through its bank facilities and intercompany funding made available through other companies within the group. The Company's forecasts and projections, taking account of reasonably possible changes in trading performance, show that the company and other companies within the group should be able to operate within the level of its current facilities. The director has a reasonable expectation that the company, and companies with which it trades, have adequate resources to continue in operational existence for the foreseeable future.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
1 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LOUGHLIN, Ryan Gerald, Dr | Director | 2022-02-21 | Sep 1981 | Irish |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JACKSON, Anthony John David, Dr | Director | 2018-06-07 | 2021-03-01 |
| MCILROY, James William, Dr | Director | 2021-03-01 | 2022-04-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Millicent Pharma Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, significant-influence-or-control-as-firm | 2018-06-07 | Ceased 2018-06-07 |
Filing timeline
Last 20 of 26 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-09-30 | AA | accounts | accounts with accounts type full |
| 2025-05-28 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-05-15 | PSC08 | persons-with-significant-control | notification of a person with significant control statement |
| 2025-03-25 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-08-21 | AA | accounts | accounts with accounts type full |
| 2024-05-15 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-10-06 | AA | accounts | accounts with accounts type full |
| 2023-06-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-09-30 | AA | accounts | accounts with accounts type full |
| 2022-06-06 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-04-15 | TM01 | officers | termination director company with name termination date |
| 2022-02-21 | AP01 | officers | appoint person director company with name date |
| 2021-08-17 | AA | accounts | accounts with accounts type full |
| 2021-06-22 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-03-15 | TM01 | officers | termination director company with name termination date |
| 2021-03-15 | AP01 | officers | appoint person director company with name date |
| 2020-10-15 | AA | accounts | accounts with accounts type full |
| 2020-06-09 | CS01 | confirmation-statement | confirmation statement with updates |
| 2020-01-08 | SH01 | capital | capital allotment shares |
| 2020-01-08 | RESOLUTIONS | resolution | resolution |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
21.2
COLD
/ 100
- Filings velocity 25
- Capital events 0
- Officer churn 0
- Headcount trajectory 50
- Accounts trajectory 50
- 3 filing(s) in last 12 months